Historical record - last NADAC effective date: 12/1/2014
Product Information
UROCIT-K SR 10 MEQ TABLET is a brand product labeled by Mission Pharmacal Company, priced at $2.0855 per EA under NDC 00178061001. Its NADAC has been published 108 times since Nov 28, 2013.
FDA first approved this application on Aug 30, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the potassium citrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 meq/1
Manufacturer
Mission Pharmacal CompanyNDC
00178061001
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
12/1/2014
Active Ingredients
POTASSIUM CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA019071FDA Approved
8/30/1985
TE Code
AB
On Market Since
9/1/1992
Pharmacological Classes
Price Statistics
The NADAC for UROCIT-K SR 10 MEQ TABLET has been published 108 times since Nov 28, 2013, and over the history we have for it it has risen 106.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0855 per EA |
|---|---|
| All-time high | $2.0855 (Dec 16, 2015) |
| All-time low | $1.0100 (Nov 28, 2013) |
| Median price | $2.0358 |
| Average price | $1.8429 |
| Largest weekly change | +40.0% (Dec 25, 2013) |
| Weeks tracked | 108 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+106.5%
Last surveyed Dec 16, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of UROCIT-K SR 10 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for UROCIT-K SR 10 MEQ TABLET, manufactured by Mission Pharmacal Company, is $2.0855 per EA (NDC 00178061001), effective Dec 16, 2015.
How has the price of UROCIT-K SR 10 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for UROCIT-K SR 10 MEQ TABLET has risen 106.5%. It has been tracked across 108 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for UROCIT-K SR 10 MEQ TABLET?
Since Nov 28, 2013, the NADAC for UROCIT-K SR 10 MEQ TABLET has ranged from a low of $1.0100 (Nov 28, 2013) to a high of $2.0855 (Dec 16, 2015), with a median of $2.0358 per EA.
Are there cheaper alternatives to UROCIT-K SR 10 MEQ TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CITRATE ER 10 MEQ TB, is $0.1798 per EA — about 91% below UROCIT-K SR 10 MEQ TABLET.
Who manufactures UROCIT-K SR 10 MEQ TABLET?
UROCIT-K SR 10 MEQ TABLET (NDC 00178061001) is labeled by Mission Pharmacal Company, and CMS classifies it as a brand product.